Dec 07


Drug Delivery to the Lungs (DDL) 2022

Stop by to learn about Solstice® Air, a breakthrough medical propellant currently in clinical development for pressurized metered dose inhalers (pMDIs) with the ability to help reduce greenhouse gas emissions.

Edinburgh, United Kingdom

Dec 07 - Dec 09, 2022

Solstice® Air (HFO-1234ze(E), cGMP) is a near-zero global warming potential (GWP) alternative to hydrofluorocarbons.  Solstice Air is non-flammable (per ASTM E-681 and ISO 10156), non-ozone depleting, and VOC-exempt (U.S. EPA and CARB).